Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study

Esther Aspinall, Amanda Weir, R Sacks-Davis, T Spelman (Translator), Jason Grebely, P Higgs, Sharon Hutchinson, Margaret Hellard

Research output: Contribution to journalArticle

Abstract

People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.
Original languageEnglish
Pages (from-to)179-182
Number of pages4
JournalInternational Journal of Drug Policy
Volume25
Issue number1
Early online date6 Dec 2013
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Hepatitis C
Hepacivirus
Pharmaceutical Preparations

Keywords

  • Hepatitis C
  • people who inject drugs
  • risk behaviours

Cite this

Aspinall, Esther ; Weir, Amanda ; Sacks-Davis, R ; Spelman, T ; Grebely, Jason ; Higgs, P ; Hutchinson, Sharon ; Hellard, Margaret. / Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. In: International Journal of Drug Policy. 2014 ; Vol. 25 , No. 1. pp. 179-182.
@article{6a341f77d82740bcb7c58232dac12f8e,
title = "Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study",
abstract = "People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.",
keywords = "Hepatitis C, people who inject drugs, risk behaviours",
author = "Esther Aspinall and Amanda Weir and R Sacks-Davis and T Spelman and Jason Grebely and P Higgs and Sharon Hutchinson and Margaret Hellard",
year = "2014",
month = "1",
doi = "10.1016/j.drugpo.2013.08.005",
language = "English",
volume = "25",
pages = "179--182",
journal = "International Journal of Drug Policy",
issn = "0955-3959",
publisher = "Elsevier B.V.",
number = "1",

}

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. / Aspinall, Esther; Weir, Amanda; Sacks-Davis, R; Spelman, T (Translator); Grebely, Jason; Higgs, P; Hutchinson, Sharon; Hellard, Margaret.

In: International Journal of Drug Policy, Vol. 25 , No. 1, 01.2014, p. 179-182.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study

AU - Aspinall, Esther

AU - Weir, Amanda

AU - Sacks-Davis, R

AU - Grebely, Jason

AU - Higgs, P

AU - Hutchinson, Sharon

AU - Hellard, Margaret

A2 - Spelman, T

PY - 2014/1

Y1 - 2014/1

N2 - People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.

AB - People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this is currently limited. The aim of this study was to investigate whether informing PWID of their HCV diagnosis was associated with a change in injecting behaviour.

KW - Hepatitis C

KW - people who inject drugs

KW - risk behaviours

U2 - 10.1016/j.drugpo.2013.08.005

DO - 10.1016/j.drugpo.2013.08.005

M3 - Article

VL - 25

SP - 179

EP - 182

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

IS - 1

ER -